Podcasts about Johns Hopkins

This hour is all about the importance of rest, and how to rest well. Plus, we'll talk about the role of rest in religion, and look at the history of "the rest cure" in medicine. GUESTS: Alex Soojung-Kim Pang: Author of Rest: Why You Get More Done When You Work Less, and Shorter: Work Better, Smarter, and Less—Here's How among other books Kristen Lucken: Program chair of religious studies, and lecturer in religion, sociology, and global studies at Brandeis University Alicia Puglionesi: Writer, historian, lecturer at Johns Hopkins, and author of In Whose Ruins: Power, Possession, and the Landscapes of American Empire, among other books Join the conversation on Facebook and Twitter. Subscribe to The Noseletter, an email compendium of merriment, secrets, and ancient wisdom brought to you by The Colin McEnroe Show. The Colin McEnroe Show is available as a podcast on Apple Podcasts, Spotify, Amazon Music, TuneIn, Listen Notes, or wherever you get your podcasts. Subscribe and never miss an episode! Colin McEnroe, Cat Pastor, Isaac Moss, and Dylan Reyes contributed to this show, which originally aired on December 26, 2024. Support the show: http://www.wnpr.org/donateSee omnystudio.com/listener for privacy information.

Today on the program, the US entered the conflict between Israel and Iran by striking three of its key nuclear sites. Fareed speaks with head of the International Atomic Energy Agency Rafael Grossi about the damage caused by the attack.   Then, why did President Trump decide to enter the conflict? Fareed speaks to CFR President Emeritus Richard Haas and retired Admiral James Stavridis.   Finally, how are leaders in Iran and Israel changing their strategies moving forward and will these strikes usher in a new era in the Middle East? Fareed is joined by Johns Hopkins' Vali Nasr and Columbia University's Nadav Eyal.   GUESTS: Rafael Grossi (@rafaelmgrossi), James Stavridis (@stavridisj), Richard Haass (@RichardHaass), Vali Nasr (@vali_nasr), Nadav Eyal (@Nadav_Eyal) Learn more about your ad choices. Visit podcastchoices.com/adchoices

This engaging and informative webinar explores the role of OX40 and OX40L in pediatric dermatology. OX40: Innovative Insights and Therapeutic Potential in Pediatric Dermatology brings together experts in the field to discuss emerging research, mechanisms of action, and the implications of targeting the OX40 pathway for treating chronic inflammatory skin diseases in children. To view the video version of this webinar, please click here. Disclosures:Lawrence Eichenfield, MD has served as a consultant, speaker, advisory board member, or investigator for AbbVie, Acrotech, Almirall, Amgen, Apogee, Arcutis, Attovia, Bristol Myers Squibb, Castle Biosciences, CorEvitas, Dermavant, Eli Lilly, Forte, Galderma, Incyte Corporation, Janssen, Johnson & Johnson, LEO Pharma, Novartis, Ortho Dermatologics, Pfizer, Regeneron, Sanofi Genzyme, Target RWE, T-Rex, and UCB.Eric Simpson, MD reports personal fees from AbbVie, Aclaris Therapeutics, Amgen, Arcutis, Astria Therapeutics, Attovia Therapeutics, Inc., Bambusa Therapeutics Inc., Castle, CorEvitas, Dermira, Eli Lilly, Evomunne, FIDE, Impetus Healthcare, Incyte, Innovaderm Reche/ Indero, Inmagene Biopharmaceuticals, Janssen, LectureLinx (LLX), Leo, NUMAB Therapeutics AG, Pfizer, Recludix Pharma, Regeneron, Roche Products Ltd, Sanofi-Genzyme, SITRYX TherapeuticsEric Simpson, MD reports grants (or serves as Principal investigator role) for AbbVie, Acrotech, Amgen, Arcutis, ASLAN, Castle, Dermavant, CorEvitas, Dermira, Eli Lilly, Incyte, Pfizer, Regeneron, Sanofi-Genzyme, Target, VeriSkinJoy Wan, MD Sun Pharmaceuticals - consulting (DMC), Astria Therapeutics - consulting (ad board), Galderma - fellowship funding (paid to Johns Hopkins)

More types of gut bacteria, or greater diversity, the healthier your microbiome. That's one message of a recent review looking at the impact of microbiome health on cancer. Kimmel Cancer Center director William Nelson at Johns Hopkins explains how gut … Which types of cancer treatment are impacted by the gut microbiome? Elizabeth Tracey reports Read More »

If the college admissions process feels overwhelming… you're not alone. And if you're a foster or adoptive parent? There are even more layers to navigate. This week on What to Expect While Fostering and Adopting, I had the absolute honor of sitting down with Cynthia Nash, a college admissions and financial aid coach with over 20 years of experience at top-tier universities like Northwestern and Vanderbilt- and friend, this conversation is packed with gold. Cynthia has helped students earn millions in scholarships and grants, including: • Five students admitted to Vanderbilt- four on full rides • Three students at Johns Hopkins- two attending completely free • A Posse Scholar at Middlebury- with all four years fully covered And that's just the beginning. Whether you're parenting a child from foster care, adoption, or not—you'll walk away from this episode equipped with tools and insight to help your teen step into a future they didn't think was possible. In this episode, we talk about: • How to navigate the college admissions process with clarity • How foster and adoptive kids need different support • Where to find scholarships and financial aid that most families miss • The power of vision, mentorship, and strategy in shaping a child's future • And why education can be one of the most powerful generational tools of healing Whether your child is in 9th grade or nearing graduation- this episode will give you real steps, renewed hope, and a fresh vision for what's possible. Now, grab your cup of coffee, get comfy, and let's dig in! XO, Christine Marie

In this conversation, Charlie Teeter shares his journey from being a collegiate runner to training for marathons, including his experiences with YouTube content creation, coaching, and balancing his professional life as a materials engineer. He discusses his training philosophy, the transition to marathon running, and his upcoming half marathon, emphasizing the importance of adaptability in both training and life. In this conversation, Charlie Teeter discusses his training progress, mental preparation for upcoming races, and the balance between personal goals and public expectations as a YouTuber. He reflects on his experiences in Oregon's running community, his aspirations for the Olympic Trials, and his college journey at Johns Hopkins, emphasizing the lessons learned and the importance of enjoying the sport.Subscribe to Charlie's YouTube ChannelSUPPORT BOMBASWe're very excited to have Bombas sponsoring the podcast this month! We're huge fans so much so that Stu wore a pair of the ⁠⁠⁠performance running socks⁠⁠⁠ for his marathon last month and walked away without any blisters. For every pair purchased, Bombas donates a pair to someone facing homelessness, and they've donated over 150 million essential clothing items.  For D3 Glory Days listeners only: use code GLORYDAYS21 for 21% off your first order on Bombas.com and GLORYDAYS15 for 15% off for returning customers.* *One time use per customer, expires July 30th, 2025. How to Support D3 Glory Days:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Shirts⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠THE NEWSLETTER!⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠D3 Glory Days Venmo⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠We launched a Patreon!⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Subscribe and leave us a review on Apple Podcasts⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠,⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Strava⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

This Day in Legal History: Georgia v. McCollumOn June 18, 1992, the U.S. Supreme Court issued a landmark decision in Georgia v. McCollum, 505 U.S. 42 (1992), holding that criminal defendants cannot use peremptory challenges to exclude jurors on the basis of race. This decision extended the logic of Batson v. Kentucky—which barred prosecutors from racially discriminatory jury strikes—to defense attorneys, ensuring both sides are bound by the Equal Protection Clause. The case involved white defendants in Georgia who sought to remove Black jurors, prompting the state to challenge the defense's strikes as racially biased.The Court, in a 7–2 opinion written by Justice Blackmun, reasoned that racial discrimination in jury selection, regardless of the source, undermines public confidence in the justice system and the constitutional guarantee of a fair trial. It emphasized that the courtroom is not a private forum and that all participants—prosecutors, defense attorneys, and judges—must adhere to constitutional principles.Importantly, the decision addressed the state action requirement, acknowledging that while defense attorneys are not state actors in the traditional sense, their participation in the jury selection process is conducted under judicial supervision and is thus attributable to the state. This broadened the scope of equal protection enforcement in criminal proceedings.The ruling was a major step toward eradicating racial bias in the judicial process, reinforcing that justice must not only be impartial but also be perceived as such. By holding defense attorneys to the same standard as prosecutors, the Court ensured that the integrity of jury selection is preserved across the board. The decision also highlighted the evolving understanding of the judiciary's role in preventing systemic discrimination, even in adversarial settings.Georgia v. McCollum remains a critical precedent in both constitutional law and criminal procedure, illustrating the Court's commitment to fairness in one of the most fundamental aspects of the legal system—trial by jury.U.S. District Judge Julia Kobick expanded a prior injunction, blocking the Trump administration's passport policy that restricted transgender, nonbinary, and intersex individuals from obtaining passports reflecting their gender identity. Kobick found that the State Department's revised policy—mandating passports list only “biological” sex at birth—likely violated the Fifth Amendment by discriminating on the basis of sex and reflecting irrational bias.Initially, the injunction applied only to six plaintiffs, but Kobick's ruling now grants class-action status, halting enforcement of the policy nationwide. The policy stems from an executive order signed by Trump after returning to office in January 2025, directing all federal agencies to recognize only two sexes and abandon the gender marker flexibility introduced under the Biden administration in 2022.The ruling marks a legal setback for the administration's effort to reimpose binary sex classifications across federal documents. The ACLU, representing the plaintiffs, called it a critical win for transgender rights. The White House condemned the ruling as judicial overreach. The broader case remains ongoing.US judge blocks Trump passport policy targeting transgender people | ReutersEducational toy company Learning Resources petitioned the U.S. Supreme Court to take up its challenge to President Donald Trump's tariffs before lower court appeals conclude. The company argues that Trump's use of the International Emergency Economic Powers Act (IEEPA) to impose broad tariffs is unconstitutional and economically damaging, citing a May 29 district court ruling that found the tariffs illegal. That decision, however, is currently stayed pending appeal.Learning Resources' CEO, Rick Woldenberg, warned that delaying Supreme Court review could cost American businesses up to $150 billion due to ongoing tariff-related costs. He described the tariffs as a hidden tax and accused the government of forcing importers to act as involuntary tax collectors.Two federal courts have already ruled against Trump's interpretation of IEEPA, a law historically used for targeted sanctions, not general trade policy. The administration defends the tariffs as a legal response to national emergencies like trade imbalances and drug trafficking, though critics say the justification is legally thin and economically harmful.While rare, the Supreme Court has expedited cases of national significance in the past, such as Biden's student loan forgiveness plan. A key appeals court hearing on Trump's tariff authority is scheduled for July 31.Small business seeks early Supreme Court review of Trump's tariffs | ReutersA federal judge has also temporarily blocked the Trump administration from enforcing a new Department of Defense policy that would cap indirect cost reimbursements to universities at 15%. The move came in response to a lawsuit filed by 12 research institutions—including MIT and Johns Hopkins—as well as major academic associations. These groups argued that the cap violated existing federal regulations and congressional intent.The Department of Defense had framed the policy as a cost-saving measure, with Defense Secretary Pete Hegseth claiming it could save up to $900 million annually. However, universities rely on indirect cost reimbursements to fund infrastructure, staff, and equipment that support research across multiple projects—not just the ones directly funded.The ruling by Judge Brian Murphy, a Biden appointee, mirrors earlier judicial blocks of similar funding cuts proposed by the NIH and Department of Energy. A hearing is scheduled for July 2 to determine whether a longer-term injunction should be issued. The case highlights growing legal resistance to the administration's broader push to reduce federal spending on scientific research.US judge blocks Defense Department from slashing federal research funding | ReutersThe U.S. Supreme Court upheld Tennessee's law banning puberty blockers and hormone therapy for transgender minors in a 6–3 decision that sets a national precedent and effectively greenlights similar restrictions in over 20 states. Writing for the majority, Chief Justice Roberts concluded that the law neither classifies based on sex nor targets transgender status, and thus only required rational basis review—not heightened constitutional scrutiny. The Court accepted Tennessee's framing of the law as neutral and medically cautious, not discriminatory, citing European health policy shifts and purported uncertainty around gender-affirming care as justification.Critics, including the Court's liberal bloc, argued the law does in fact discriminate based on sex and gender identity by banning medical treatment only when it aims to affirm a transgender identity. Justice Sotomayor, in dissent, emphasized that the law's language and application plainly hinge on a minor's “sex as assigned at birth,” drawing troubling parallels to older jurisprudence that permitted covert forms of discrimination under the guise of neutrality.The ruling marks a major rollback of legal protections for transgender youth, ignoring years of precedent that increasingly recognized transgender identity as a constitutionally protected status. By lowering the scrutiny threshold and deferring to legislative “uncertainty,” the Court provided a road map for states to restrict gender-affirming care through general, non-explicitly discriminatory language. The majority's refusal to engage with medical consensus or the real-world impact on transgender youth reveals a troubling judicial posture: one that values legislative deference over individual rights, even when the stakes include physical and psychological harm to a vulnerable group.Supreme Court Upholds Curbs on Treatment for Transgender Minors This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.minimumcomp.com/subscribe

In this powerful conversation, Shari sits down with Andres Lares, Managing Partner and CEO of Shapiro Negotiations Institute (SNI), to talk about what it really takes to become a confident, skilled negotiator in both business and life. From teaching at Johns Hopkins to consulting with major sports franchises and leading tech companies, Andres brings a unique perspective on persuasion, performance, and practical success. In this episode, we discuss: – Why negotiation isn't about being aggressive—it's about being strategic – The science behind persuasion (and how to use it ethically) – The one mindset shift that will instantly make you a better negotiator – How to overcome negotiation anxiety and self-doubt – Real-world negotiation tips you can use in your next raise request, contract discussion, or tricky conversation – How virtual reality and AI are transforming the way we train negotiation skills You'll walk away with: A framework for approaching every negotiation with confidence and clarity Tools to communicate your value without second-guessing yourself Insights from one of the most respected negotiation experts in the country Permission to stop winging it—and start negotiating with purpose Learn more about your ad choices. Visit megaphone.fm/adchoices

This week's headlines include stories from workers at Safeway, Fenway Park, the Louvre, Johns Hopkins, Butler Hospital, and the video game industry. For our first story, we discuss a recent report in Truthout on the massive wins made by mental health workers at Kaiser Permanente after their epic strike. Panamanian workers have continued to fight against attacks on their rights and social security, as their government turns to legal repression. Universities across the country have gone to extreme lengths to suppress Palestine protests, this week we discuss an expose of dystopian (and sloppy) surveillance at the University of Michigan. Canada Post workers are once again at a crossroads between an intransigent government and the possibility of another strike. Finally, we check in on the growing coalition in the labor movement and the broader working class to organize against ICE terrorism. Join the discord: discord.gg/tDvmNzX  Follow the pod at instagram.com/workstoppage, @WorkStoppagePod on Twitter,  John @facebookvillain, and Lina @solidaritybee

Das Eisschild Grönlands schwindet und mit ihm gleitet Camp Century langsam ins Nordpolarmeer. Ein Podcast über eine Umweltkatastrophe aus Nachlässigkeit. Ein Podcast vom Pragmaticus.Das Thema:Was werden Sie in diesem Podcast hören? „Eine bizarre Geschichte“, so fasst es Horst Machguth zusammen. Der Glaziologe an der Universität Lausanne hat sie 2016 publik gemacht: Es geht um eine verlassene Militärbasis auf Grönland. Camp Century in der Arktis lag einmal tief im Firn Grönlands vergraben. Die US-Militärbasis sollte nach dem Sputnikschock im Oktober 1957 eine Bastion gegen die Sowjetunion sein und war für die Zukunft gemacht. Diese Zukunft ist jetzt da, und sie ist anders als die Erbauer glaubten. Das Eis schmilzt, und die Stadt unter dem Eis gleitet unaufhaltsam in das Nordpolarmeer. Eine tödliche Fracht voller Schwermetalle, Altöl und radioaktivem Abfall.Camp Century wurde schon 1967 aufgegeben, der Kalte Krieg hatte neue Technologien und Wege gefunden. Schon zu Beginn der Grabungen war klar, dass der Firn keine Stollen trägt, dass die Idee mit den Abschussrampen im Eis nicht funktioniert. Es lohnt die Frage: Wie konnte es zu einer derartigen Fehleinschätzung der Folgen kommen? Antworten geben: Horst Machguth, der Glaziologe, der die Welt als Erster über das Vermächtnis von Camp Century informierte; Jakob Abermann, ein Meteorologe und Gletscherforscher, der das Schicksal des Eisschilds auf Grönland erforscht und Heinz Gärtner, Politologe und Experte für den Kalten Krieg.Camp Century liegt etwa 240 Kilometer östlich der Thule Airbase (Pittufik), das ist jene, die der Vizpräsident der USA, J.D. Vance, Ende März 2025 besuchte. Für die Thule Airbase wurden die ursprünglichen Bewohner zwangsumgesiedelt, von Uummannaq (Thule) in das neu gegründete Qaanaaq.Gebraucht hat man die Militär-Basis im Firn nie. Sie war eine reine Cover-Aktion. Doch auch als solche war sie schon überflüssig, bevor sie fertig war.Unsere Gäste in dieser Folge: Jakob Abermann ist Meteorologe und forscht an der Universität Graz am Institut für Geographie und Raumforschung. In seiner wissenschaftlichen Arbeit dreht sich alles um Klima, Eis und Schnee: Es geht um Wechselwirkungen zwischen Kryo- und Atmosphäre. Nach Forschungsaufenthalten in Chile, ist Grönland sein Forschungsschwerpunkt und wegen der oft jahrelangen Feldforschung häufig der Lebensmittelpunkt. Auf Grönland erhobene Daten sollen Aufschluss über Vergangenheit und Zukunft des Klimawandels geben.Heinz Gärtner ist Politikwissenschaftler, er lehrt an der Universität Wien, leitet den Beirat des International Institute for Peace (IIP) und ist Vorsitzender des Strategie- und Sicherheitspolitischen Beirats des Österreichischen Bundesheeres. Er leitete als wissenschaftlicher Direktor das Österreichische Institut für internationale Politik – oiip. Seine Forschung über die USA, Fragen internationaler Sicherheit, Abrüstung und Rüstungskontrolle führten ihn unter anderem an die Universitäten Erlangen, Stanford, Oxford und die Johns Hopkins in Washington, an denen er als Gastprofessor tätig war. Heinz Gärtner hat neben Fachbeiträgen zahlreiche Bücher geschrieben, zuletzt erschien von ihm Ideen zum positiven Frieden. Der Kalte Krieg ist einer seiner Forschungsschwerpunkte.Horst Machguth ist Glaziologe. Er lehrt und forscht an der Université de Fribourg in der Schweiz zur Massenbilanz von Gletschern und Eisschilden. Seine Forschung ist für das Monitoring der globalen Eisressourcen bedeutsam, ebenso wie für das Verständnis der geophysikalischen Prozesse in Eisschilden und Gletschern. Das grönländische Eisschild ist einer seiner Schwerpunkte.Credits:Trump: „One way or another“: NBCNews, 4. März 2025Sputnik: www.youtube.com/watch?v=lfnfNe31fmYMette Frederiksen: „Not for sale“, abc-News, 19. August 2019Trump: „Not rule out“ NBC News, Interview in Palm Beach, Fla., am 2. Mai 2025Mette Frederiksen 2025: ReutersPolar Wind by Fission9 --https://freesound.org/s/521820/-- License: Creative Commons 0Camp Century: The City under the Ice, US Army 1964Rocket Launch.flac by qubodup -- https://freesound.org/s/182794/-- License: Creative Commons 0Schmelzendes Eis: Drop Ice Snow melting Cave ORTF inside by Sacha.Julien --https://freesound.org/s/725343/-- License: Creative Commons 0TwinOtter.mp3 by rd42 --https://freesound.org/s/102436/-- License: Sampling+  Dies ist ein Podcast von Der Pragmaticus. Sie finden uns auch auf Instagram, Facebook, LinkedIn und X (Twitter).

Today on the show, guest anchor Bianna Golodryga speaks with The New York Times' David Sanger after a weekend of strikes between Iran and Israel. They discuss this escalating conflict and what it means for the future of US-Iran nuclear negotiations.   Next, Israeli Foreign Minister Gideon Sa'ar joins the show to tell Bianna what his country is hoping to achieve by attacking Iran's nuclear facilities.   Then, Johns Hopkins professor Vali Nasr and The New Yorker's Susan Glasser speak to Bianna about how the US will respond to the conflict between Iran and Israel, as well as the significance of President Trump's military parade.   Finally, retired Major General James ‘Spider' Marks joins to discuss the military dynamics at play between Iran and Israel and what the two countries' defense capabilities might mean for the future of the conflict.   GUESTS: David Sanger (@SangerNYT), Gideon Sa'ar (@gidonsaar), Susan Glasser (@sbg1), Vali Nasr (@vali_nasr), James "Spider" Marks (@RangerSpider) Learn more about your ad choices. Visit podcastchoices.com/adchoices

Let's say you've taken the newly approved blood test for Alzheimer's disease and the results indicate the presence of tau and amyloid in your brain, so you're at risk.  Abhay Moghakar, a neurologist and blood biomarkers expert at Johns Hopkins, says … What are your options if a new blood test says you are at risk for Alzheimer's disease? Elizabeth Tracey reports Read More »

High blood biomarkers for Alzheimer's disease found by the newly FDA approved blood test indicate the presence of two proteins in the brain called amyloid and tau. Abhay Moghakar, a neurologist and blood biomarkers expert at Johns Hopkins, says some … What are current studies doing when high levels of blood biomarkers for Alzheimer's are found? Elizabeth Tracey reports Read More »

Being short of breath is a terrible feeling, most people agree, and it's a feature of many lung diseases, especially as they progress. Lung expert Anna Gersten at Johns Hopkins describes how a breathlessness clinic came to be at Hopkins … What is a breathlessness clinic? Elizabeth Tracey reports Read More »

Breathlessness clinic is a new approach at Johns Hopkins to assist people with chronic lung diseases to live their best lives with these often debilitating conditions. Anna Gersten, a lung expert and director of the clinic, explains who would benefit. … Who is suitable for a breathlessness clinic visit? Elizabeth Tracey reports Read More »

You may have heard of a new blood test for Alzheimer's disease just approved by the FDA. Abhay Moghakar, a neurologist and blood biomarkers expert at Johns Hopkins, says even if you are older and have symptoms of the disease, … People who develop dementia as they age most often have a mixed type, Elizabeth Tracey reports Read More »

John A. Read is no stranger to reaching for the stars—both figuratively and literally. Fresh off earning his Master's in Space Systems Engineering from Johns Hopkins (without an undergrad in engineering—yes, really), John joins Beth to explore his fascinating journey from finance to astrophysics, and from a $15 pharmacy telescope to founding Stargaze Nova Scotia, a public dark-sky observatory. Along the way, John shares how a spark of curiosity from a Chris Hadfield novel launched him into grad school, how he's helping democratize astronomy through smart telescopes and best-selling books, and why his family's space-inspired creative projects continue to inspire new generations of stargazers. Beth and John also explore the rapid evolution of space tech, investing in emerging space companies, and what celestial sights to look forward to this summer—including a can't-miss list of stellar showstoppers for both casual observers and seasoned skywatchers. About John A. Read: John is an award-winning astronomy author, YouTuber, and outreach educator whose books—including 50 Things to See with a Telescope—have helped thousands learn to stargaze. His company, Learn to Stargaze, creates accessible astronomy resources and experiences for all ages. John also leads Stargaze Nova Scotia and helps manage the historic Abbey Ridge Observatory, bringing the wonders of the cosmos to the public through tours, events, and online content. John's family is equally starry-eyed—his wife and daughter create space-themed art and poetry, including the first augmented-reality space poetry book inspired by a trip to orbit! Mentioned in this episode:

This episode, recorded live at the Becker's 3rd Annual Spring Payer Issues Roundtable, features Dr. Aisha Rahim, Medical Director and Co-Lead, AI Governance Council, Johns Hopkins Health Plans (JHHP). Dr. Rahim discusses how JHHP is leveraging artificial intelligence to manage costs, close care gaps, advance health equity, and enhance member engagement across a diverse population.

In this special episode of Inside GRAPPA, we delve into the growing impact of the Patient Research Partner (PRP) Network—an essential part of GRAPPA's mission to integrate the patient voice into scientific research on psoriatic disease.Host Fabian Proft is joined by two influential PRPs: Maarten de Wit from the Netherlands and Suzanne Grieb* from the United States. Together, they explore the critical role of PRPs, the evolution of the network since its inception in 2013, and how these dedicated patient collaborators are shaping treatment guidelines, influencing steering committees, and helping recruit the next generation of partners.What does it really mean to live the principle of “Nothing about us without us”? What kinds of challenges—and transformative insights—do patients bring to the research table? And what can researchers learn from patient partners about improving outcomes, communication, and the research agenda itself?Listen in as we discuss:The origins and global growth of the PRP networkReal-world experiences from PRPs living with psoriatic arthritisHow patients are steering research priorities, not just participating in themStrategies for recruiting and onboarding new patient partnersWhere the network is headed—and how you might get involved

About this episode: A recent MAHA report from the Department of Health and Human Services stated that a trio of common procedures for children—tonsillectomy, adenoidectomy, and tympanostomy tube (ear tube) placement—“cause harm without offering benefits.” In this episode: a look at what these surgeries are, the advantages and risks, and what the report said—and didn't say—about the value of these procedures when properly indicated. Guests: Dr. Emily Boss is the director of pediatric otolaryngology at Johns Hopkins. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: The MAHA Report: Make Our Children Health Again—The White House MAHA kids' health report misinforms about tonsillectomies and ear tubes—STAT (Opinion) Tympanostomy Tubes or Medical Management for Recurrent Acute Otitis Media—The New England Journal of Medicine Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

The Big Unlock Podcast · Scaling With Autonomous AI for Diabetic Retinopathy Screening – Podcast with Alvin Liu In this episode, Dr. T.Y. Alvin Liu, Inaugural Director, James P Gills Jr MD and Heather Gills AI Innovation Center at Johns Hopkins Medicine shares his journey in healthcare AI, with a focus on image analysis and real-world applications. Dr. Liu discusses the FDA-approved autonomous AI system for diabetic retinopathy screening, which enables early detection in primary care settings and improves screening adherence. He outlines successful AI implementations at Johns Hopkins, including prior authorization pilots using generative AI and the importance of operational understanding in deployment. He also discussed the intersection of value-based medicine and artificial intelligence, and the challenges of implementing successful AI programs.  At the enterprise level, Dr. Liu emphasizes the need for strong AI governance to assess safety, effectiveness, and ROI. He outlines key challenges for AI startups, especially around reimbursement and regulation, and urges them to pursue sustainable business models. He also suggests closer collaboration among startups, VCs, and integrated health systems to bridge the gap between innovation and real-world adoption, essential for scaling AI responsibly and delivering long-term value in healthcare. Take a listen.

Cyberattacks on big companies get plenty of attention, but small businesses are hit about four times as often. A New Orleans restaurant owner lost thousands after her Facebook was hacked. The Gulf States Newsroom's Stephan Bisaha shares why hackers are targeting small businesses. There's been roughly $11 billion in cuts to university research funding since President Trump took office in January. Trump has cited widespread political bias, including antisemitism, as the reason for these cuts, saying universities have forfeited the right to taxpayer support. While institutions like Harvard and Johns Hopkins are temporarily self-funding their research, not every institution has the means to do this. Robert Twilley,  a professor and vice president at the Office of Research & Economic Development at Louisiana State University joins us to discuss how research funding cuts could impact schools like LSU.Recent national analysis shows Louisiana is bucking a national trend related to state budgets. It's called revenue volatility, and the report from The Pew Charitable Trusts shows Louisiana's is actually lower than most of the nation.Justin Theal, senior officer with The Pew Charitable Trusts tells us how this rating relates to the state's budget.___Today's episode of Louisiana Considered was hosted by Adam Vos. Our managing producer is Alana Schreiber. We get production support from Garrett Pittman and our assistant producer Aubry Procell.You can listen to Louisiana Considered Monday through Friday at noon and 7 p.m. It's available on Spotify, the NPR App and wherever you get your podcasts. Louisiana Considered wants to hear from you!Please fill out our pitch line to let us know what kinds of story ideas you have for our show. And while you're at it, fill out our listener survey! We want to keep bringing you the kinds of conversations you'd like to listen to.Louisiana Considered is made possible with support from our listeners. Thank you!

This episode, recorded live at the Becker's 3rd Annual Spring Payer Issues Roundtable, features Dr. Aisha Rahim, Medical Director and Co-Lead, AI Governance Council, Johns Hopkins Health Plans (JHHP). Dr. Rahim discusses how JHHP is leveraging artificial intelligence to manage costs, close care gaps, advance health equity, and enhance member engagement across a diverse population.

If you're a physician with at least 5 years of experience looking for a flexible, non-clinical, part-time medical-legal consulting role… ...Dr. Armin Feldman's Medical Legal Coaching program will guarantee to add $100K in additional income within 12 months without doing any expert witness work. Any doctor in any specialty can do this work. And if you don't reach that number, he'll work with you for free until you do, guaranteed. How can he make such a bold claim? It's simple, he gets results…  Dr. David exceeded his clinical income without sacrificing time in his full-time position. Dr. Anke retired from her practice while generating the same monthly consulting income.  And Dr. Elliott added meaningful consulting work without lowering his clinical income or job satisfaction. So, if you're a physician with 5+ years of experience and you want to find out exactly how to add $100K in additional consulting income in just 12 months, go to arminfeldman.com.                                                          =============== Learn the business and management skills you need by enrolling in the University of Tennessee Physician Executive MBA program at nonclinicalphysicians.com/physicianmba. Get the FREE GUIDE to 10 Nonclinical Careers at nonclinicalphysicians.com/freeguide. Get a list of 70 nontraditional jobs at nonclinicalphysicians.com/70jobs.                                                                                                 =============== Dr. Meredith Loveless, an OB-GYN physician, shares her career shift from academic medicine to becoming Chief Medical Officer for CGS Administrators, a Medicare Administrative Contractor. After helping establish pediatric and adolescent gynecology programs at Johns Hopkins and the University of Louisville, she found herself carrying an unsustainable workload when her department shrank from five physicians to two—prompting her to explore non-clinical paths where she could apply her experience in medical writing and policy. She describes the world of Medicare administration, where Contract Medical Directors are responsible for creating Local Coverage Determinations—policies that guide what treatments and services Medicare will cover based on medical evidence. With the introduction of the 21st Century Cures Act, these policies now require greater transparency and rigor, opening the door for physicians with strong clinical and writing backgrounds to contribute meaningfully to federal healthcare decision-making. Dr. Loveless also outlines what the role involves day-to-day, including frequent travel, collaboration with subject matter experts, and the long timelines often needed to develop and implement coverage policies. She offers a grounded look at Medicare administration, challenging misconceptions while showing how physicians can move into policy work that influences care access and quality for millions of people—bringing clinical expertise into one of healthcare's most impactful arenas. You'll find links mentioned in the episode at  nonclinicalphysicians.com/chief-medical-officer-for-a-mac/

Positive results on the newly FDA cleared blood test for Alzheimer's disease don't necessarily mean you have the disease. That's according to blood biomarkers expert Abhay Moghekar, a neurologist at Johns Hopkins. Moghekar: Whether that's the cause of your cognitive … If you get a positive result on the new blood test for Alzheimer's disease, what does that mean? Elizabeth Tracey reports Read More »

The FDA has just cleared a blood test to help make the diagnosis of Alzheimer's disease, which otherwise may require some fairly invasive methods. Blood biomarkers expert Abhay Moghekar, a neurologist at Johns Hopkins, says the test looks for the … Who is a candidate for the new blood test for Alzheimer's disease? Elizabeth Tracey reports Read More »

A blood test to screen for proteins related to Alzheimer's disease has been cleared by the FDA, and it's designed for people who are older than 55 years of age and have cognitive symptoms. Johns Hopkins neurologist Abhay Moghekar, a … What's the basis of the new blood test to screen for Alzheimer's disease? Elizabeth Tracey reports Read More »

A new blood test for Alzheimer's disease isn't a stand alone diagnostic tool. That's according to Abhay Moghekar, a blood biomarkers expert and a neurologist at Johns Hopkins. Moghekar: You would still need the clinical input in the context of … A truly comprehensive test for Alzheimer's disease may be on the horizon, Elizabeth Tracey reports Read More »

Amit Peled is a renowned Israeli-American cellist and conductor who has made a remarkable transition from growing up on a Kibbutz in Israel to becoming a Superstar Cellist and a Professor of Music at Johns Hopkins University. He's performed at Carnegie Hall, Lincoln Center, the Kennedy Center, Wigmore Hall and the Seoul Arts Center among many others. He's released over a dozen recordings and started an online cello academy. My featured song is “Because She Said So” from the album Play by my band Project Grand Slam. Spotify link.---------------------------------------------The Follow Your Dream Podcast:Top 1% of all podcasts with Listeners in 200 countries!Click here for All Episodes Click here for Guest List Click here for Guest Groupings Click here for Guest TestimonialsClick here to Subscribe Click here to receive our Email UpdatesClick here to Rate and Review the podcast—----------------------------------------CONNECT WITH AMIT:www.amitpeled.com________________________ROBERT'S RECENT SINGLES:“DAY AT THE RACES” is Robert's newest single.It captures the thrills, chills and pageantry of horse racing's Triple Crown. Called “Fun, Upbeat, Exciting!”CLICK HERE FOR THE OFFICIAL VIDEOCLICK HERE FOR ALL LINKS___________________“MOON SHOT” reflects my Jazz Rock Fusion roots. The track features Special Guest Mark Lettieri, 5x Grammy winning guitarist who plays with Snarky Puppy and The Fearless Flyers. The track has been called “Firey, Passionate and Smokin!”CLICK HERE FOR THE OFFICIAL VIDEOCLICK HERE FOR ALL LINKS____________________“ROUGH RIDER” has got a Cool, ‘60s, “Spaghetti Western”, Guitar-driven, Tremolo sounding, Ventures/Link Wray kind of vibe!CLICK HERE FOR THE OFFICIAL VIDEOCLICK HERE FOR ALL LINKS—--------------------------------“LOVELY GIRLIE” is a fun, Old School, rock/pop tune with 3-part harmony. It's been called “Supremely excellent!”, “Another Homerun for Robert!”, and “Love that Lovely Girlie!”Click HERE for All Links—----------------------------------“THE RICH ONES ALL STARS” is Robert's single featuring the following 8 World Class musicians: Billy Cobham (Drums), Randy Brecker (Flugelhorn), John Helliwell (Sax), Pat Coil (Piano), Peter Tiehuis (Guitar), Antonio Farao (Keys), Elliott Randall (Guitar) and David Amram (Pennywhistle).Click HERE for the Official VideoClick HERE for All Links—----------------------------------------Audio production:Jimmy RavenscroftKymera Films Connect with the Follow Your Dream Podcast:Website - www.followyourdreampodcast.comEmail Robert - robert@followyourdreampodcast.com Follow Robert's band, Project Grand Slam, and his music:Website - www.projectgrandslam.comYouTubeSpotify MusicApple MusicEmail - pgs@projectgrandslam.com 

Dr. Diane Hennacy Powell, neuropsychiatrist and author of "The ESP Enigma," joins me for a mind-bending exploration of consciousness, savant abilities, and the limitations of materialist science. Trained at Johns Hopkins under a neurologist-turned-psychiatrist, Diane has spent decades investigating phenomena that challenge our fundamental assumptions about how the brain works. We dive deep into why the scientific establishment reacts so emotionally to consciousness research, her fascinating work with autistic savants, and why she believes the brain functions as a navigation tool for consciousness rather than its creator. This is one of those conversations that might just upgrade your entire worldview. I hope you enjoy the conversation as much as I did. For the full transcript, episode takeaways, and bucketloads of other goodies designed to make you go, “Hmm, that's interesting!,” check out our Substack. Important Links: Personal Website The Telepathy Tapes Twitter LinkedIn Show Notes: Dr. Powell's Journey through Science Early Interest in Savants Filter Failure and Consciousness Why People Reject Obvious Data Why are Savants different from Neurotypical People? The Sheep Goat Effect in Parapsychology The Brain as a Navigational Tool Improving our own Intuition and Focus Dr. Diane's work on Twins Speculations in Post-Materialism Dr. Diane as Empress of the World Books Mentioned: The Man Who Mistook His Wife for a Hat; by Oliver Sacks The ESP Enigma; by Diane Hennacy Powell What Is Life? The Physical Aspect of the Living Cell; by Erwin Schrödinger Mind Over Back Pain; by Dr. John Sarno

Send us a textThe podcast has returned, post op! Steve had a double lung transplant since the last episode, and the boys are happy to be back. They decide the greatest organ to swap, share a ton of funny stories, Steve thanks his Johns Hopkins doctors and nurses, and they cover the gruesome details of Jeremy Renner's own organ problems. This episode is jam-packed with fun!Support the show Steve's Diner Podcast on YouTube! https://youtube.com/@StevesDinerPodcast Merch Now Available! https://www.teepublic.com/user/steve-sdinerpodcast Follow Steve's Diner Podcast on Facebook, Instagram and Tik Tok: @stevesdinerpodcast Follow "Busboy" Steve on Tik Tok: @ceoofmaryland For Audio Projects: @DevinAudio Intro song by richportercrew. Look for them on Fiverr (app). Great to work with! Guitar music by the legend, Tom Lagana: http://www.tomlagana.net

Support the show to get full episodes, full archive, and join the Discord community. The Transmitter is an online publication that aims to deliver useful information, insights and tools to build bridges across neuroscience and advance research. Visit thetransmitter.org to explore the latest neuroscience news and perspectives, written by journalists and scientists. Read more about our partnership. Check out this series of essays about representations: What are we talking about? Clarifying the fuzzy concept of representation in neuroscience and beyond Sign up for Brain Inspired email alerts to be notified every time a new Brain Inspired episode is released. To explore more neuroscience news and perspectives, visit thetransmitter.org. What do neuroscientists mean when they use the term representation? That's part of what Luis Favela and Edouard Machery set out to answer a couple years ago by surveying lots of folks in the cognitive sciences, and they concluded that as a field the term is used in a confused and unclear way. Confused and unclear are technical terms here, and Luis and Edouard explain what they mean in the episode. More recently Luis and Edouard wrote a follow-up piece arguing that maybe it's okay for everyone to use the term in slightly different ways, maybe it helps communication across disciplines, perhaps. My three other guests today, Frances Egan, Rosa Cao, and John Krakauer wrote responses to that argument, and on today's episode all those folks are here to further discuss that issue and why it matters. Luis is a part philosopher, part cognitive scientists at Indiana University Bloomington, Edouard is a philosopher and Director of the Center for Philosophy of Science at the University of Pittsburgh, Frances is a philosopher from Rutgers University, Rosa is a neuroscientist-turned philosopher at Stanford University, and John is a neuroscientist among other things, and co-runs the Brain, Learning, Animation, and Movement Lab at Johns Hopkins. Luis Favela. Favela's book: The Ecological Brain: Unifying the Sciences of Brain, Body, and Environment Edouard Machery. Machery's book: Doing without Concepts Frances Egan. Egan's book: Deflating Mental Representation. John Krakauer. Rosa Cao. Paper mentioned: Putting representations to use. The exchange, in order, discussed on this episode: Investigating the concept of representation in the neural and psychological sciences. The concept of representation in the brain sciences: The current status and ways forward. Commentaries: Assessing the landscape of representational concepts: Commentary on Favela and Machery. Comments on Favela and Machery's The concept of representation in the brain sciences: The current status and ways forward. Where did real representations go? Commentary on: The concept of representation in the brain sciences: The current status and ways forward by Favela and Machery. Reply to commentaries: Contextualizing, eliminating, or glossing: What to do with unclear scientific concepts like representation. 0:00 - Intro 3:55 - What is a representation to a neuroscientist? 14:44 - How to deal with the dilemma 21:20 - Opposing views 31:00 - What's at stake? 51:10 - Neural-only representation 1:01:11 - When "representation" is playing a useful role 1:12:56 - The role of a neuroscientist 1:39:35 - The purpose of "representational talk" 1:53:03 - Non-representational mental phenomenon 1:55:53 - Final thoughts

Dr. Anand Bery and Dr. David Hale join Dr. Abbie Ross, PT, NCS and Dr. Danielle Tolman, PT to discuss the process of differential diagnosis for vestibular dysfunction. Dr. Anand Bery is a neurologist and otoneurologist, with unique subspecialty fellowship training in neuro-vestibular and balance disorders. He specializes in treating patients with dizziness, vertigo, double vision and imbalance. His clinical interests include vestibular neuritis, BPPV, vestibular migraine and nystagmus.Dr. David Hale is a fellowship-trained neurologist specializing in neuro-visual and vestibular disorders. He diagnoses and treats patients with symptoms including dizziness, vertigo, oscillopsia, double vision and imbalance. Dr. Hale's patient evaluations include vestibular testing. Dr. Hale earned his medical degree at Pennsylvania State University and completed a neurology residency at the Johns Hopkins University School of Medicine. He remained at Johns Hopkins for fellowship training in vestibular and ocular-motor oto-neurology. He serves as the co-director of the Vestibular and Ocular-Motor Oto-Neurology Clinical Fellowship at Johns Hopkins. Neurology Exam Prep Podcast Episodes:Episodic Vertigo (episode 73) https://podcasts.apple.com/us/podcast/episode-73-episodic-vertigo/id1493745353?i=1000678790997 Acute Vestibulopathy (episode 68)https://podcasts.apple.com/us/podcast/episode-68-acute-vestibulopathy/id1493745353?i=1000658289413 Hosted by:

This year's WNYC Health Convening with support from the Alfred P. Sloan Foundation continues with a look at the current state of cancer research in the United States. Sudip Parikh, Ph.D., chief executive officer of the American Association for the Advancement of Science (AAAS) and executive publisher of the Science family of journals, and Otis Brawley, professor of oncology at The Kimmel Cancer Center at Johns Hopkins, a Bloomberg Distinguished Professor at Johns Hopkin and co-editor of The Cancer History Project, and Julie Rovner, chief Washington correspondent at KFF Health News and host of the What the Health? podcast, discuss what the impacts of the Trump administration's funding cuts to the National Health Institute have meant to clinical trials, and what a future without government funding to find a cure might look like should the science continue to be underfunded.

What if music, color, scent, and art could actually change your brain? Science now shows they do.Join Susan Magsamen, Executive Director of the International Arts + Mind Lab at Johns Hopkins, as she explores how art and beauty impact our brains and well-being. From the transformative power of music to the subtle magic of sensory environments, she reveals how simple aesthetic moments can boost your health and joy.

Measles cases have topped 1,000 for the first time in six years. Researchers at Johns Hopkins say most U.S. counties have seen declines in childhood vaccinations for measles, mumps and rubella. Italy's Mount Etna erupted, Europe's largest active volcano, sending ash more than four miles into the sky. Scientists warn the volcano could remain active for weeks. More than four months after wildfires tore through Southern California, homeowners are now facing rising insurance premiums — while some say they're still waiting on payouts. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

What happens when students aren't just learners—but co-pilots?  Anthony co-hosts this session with Cole Lyons, President and COO of The American Journal of Healthcare Strategy and host of The Strategy of Health Podcast. In this episode, we learn from Johns Hopkins Master of Health Administration Program Director Dr. Mark Bittle, along with MHA students Angelina Haw and Riya Patel, how students collaborate, innovate, and build a network that serve to enhance their future success. 

Many theories on how brain disorders like Alzheimer's disease begin point to proteins called amyloid beta and tau as accumulating and disrupting the function of neurons. Research by neuroscientist Paul Worley and colleagues at Johns Hopkins points to declining levels … How do neurodegenerative diseases begin? Elizabeth Tracey reports Read More »

NPTX2 is the abbreviation for a protein found in the brain that may allow much more accurate prognosis of who's at risk for developing neurocognitive disorders, including Alzheimer's disease and other dementias. That's according to Johns Hopkins neuroscientist Paul Worley, … Accurately predicting who's at risk to develop Alzheimer's disease may now be easier, Elizabeth Tracey reports Read More »

In this episode we are exploring two publications related to cancer care. In our first segment we talk to 2 authors about their research on genetic counselors and identification of patients for high-risk pancreatic cancer screening. In our second segment, Khalida interviews a genetic counselor about their study to evaluate surgical patient perspectives of genetic testing provided by a non-genetics professional.  Segment 1: “Practices and perspectives of genetic counselors about high-risk pancreatic cancer screening: A cross-sectional survey study” Amy Wiegand is a board-certified genetic counselor who specializes in cancer genetics. She graduated with her Master's in Genetic Counseling in 2017 from from the Icahn School of Medicine at Mount Sinai and has worked as a cancer genetic counselor at the Smilow Cancer Genetics and Prevention Program at Yale-New Haven Health since 2017 where she has seen over 2500 patients for a variety of hereditary cancer indications. Her research interests include hereditary pancreatic cancer and alternative delivery care models for genetic testing. Aparna is a senior genetic counseling assistant (GCA) at Smilow Cancer Genetics and Prevention Program at Yale New Haven Health where she has worked since 2019, and she has over 6 years of experience as a GCA. She holds a Master's degree in Biomedical Genetics and a Bachelor's degree in Biotechnology. She also has a varied background in administration, finance and customer service. She is a high-performing individual and was recently recognized by her colleagues as ‘Employee of the Quarter' and honored by the organization as ‘Smilow Star' for consistently going above and beyond for the patients and the co-workers and for exemplifying the health system's values. She contributes to the program in a variety of other ways outside of her role and works collaboratively with the team to create a patient centered environment. She has a strong interest in Cancer Genetics and is passionate about research. She is currently working on another research project, the abstract of which was selected for presentation in a Poster Session at 2025 ASCO (American Society of Clinical Oncology) annual meeting. She enjoys being part of a collaborative and dynamic team at Smilow Cancer Genetics and Prevention program and is excited about the upcoming research initiatives in the program. In this segment we discuss: - The significance of pancreatic cancer surveillance for high-risk individuals and why early detection plays a critical role in improving outcomes. - How genetic counselors are uniquely positioned to identify and refer individuals at high risk for pancreatic cancer, emphasizing their role in screening efforts. - An overview of the 2019 CAPS (Cancer of the Pancreas Screening) consensus guidelines and how they are applied to identify high-risk individuals for surveillance - The finding that nearly 70% of genetic counselors accurately identified individuals eligible for screening and discussed the factors that may have contributed to this high rate. - The association between provider comfort level and accuracy in identifying high-risk individuals, and discussed strategies to improve provider confidence and access to screening programs.   Segment 2: “Patient experiences of cancer genetic testing by non-genetics providers in the surgical setting” Katie Fiallos is a board-certified genetic counselor who earned her Master of Science in Genetic Counseling from the Johns Hopkins University/National Human Genome Research Institute Genetic Counseling Training program in 2017 and worked for seven years as a cancer genetic counselor at Johns Hopkins. She joined the Department of Medical and Molecular Genetics at Indiana University in August 2024. She is fluent in Spanish and provides genetic counseling in English and Spanish to participants with Parkinson's disease enrolled in the PD GENEration study. She has authored several academic papers related to genetic counseling, and her current research interests include provision of genetic counseling to Latine individuals, alternate service delivery models, and patient experiences with genetic testing and their informational desires. She lives in Michigan with her family and enjoys staying active, particularly practicing aerial silks. The research for the paper we're discussing was done while she was at Johns Hopkins and was funded by the Jennifer L. Brager Memorial Research award through the Johns Hopkins Kimmel Cancer Center.   In this segment we discuss: - Why hereditary cancer genetic testing is becoming increasingly important for patients with breast cancer, especially in relation to surgical decision-making. - The findings that patients preferred genetic testing at an existing appointment shortly after diagnosis, and explored how this timing affects their overall experience. - How many patients had already considered or wanted genetic testing before it was offered, shedding light on patient awareness and readiness. - Why patients were primarily motivated by concern for relatives and a desire for complete information, rather than surgical decision-making. - Gaps in patient-provider communication identified in the study and suggested ways for providers to address these issues in clinical practice.   Would you like to nominate a JoGC article to be featured in the show? If so, please fill out this nomination submission form here. Multiple entries are encouraged including articles where you, your colleagues, or your friends are authors.   Stay tuned for the next new episode of DNA Dialogues! In the meantime, listen to all our episodes Apple Podcasts, Spotify, streaming on the website, or any other podcast player by searching, “DNA Dialogues”.    For more information about this episode visit dnadialogues.podbean.com, where you can also stream all episodes of the show. Check out the Journal of Genetic Counseling here for articles featured in this episode and others.    Any questions, episode ideas, guest pitches, or comments can be sent into DNADialoguesPodcast@gmail.com.  DNA Dialogues' team includes Jehannine Austin, Naomi Wagner, Khalida Liaquat, Kate Wilson and DNA Today's Kira Dineen. Our logo was designed by Ashlyn Enokian. Our current intern is Sydney Arlen.

Joe Pardavila welcomes Dr. Marschall Runge, Dean of the University of Michigan Medical School and author of The Great Healthcare Disruption: Big Tech, Bold Policy, and the Future of American Medicine. Dr. Runge shares his bold vision for transforming the U.S. healthcare system, tackling pressing issues like physician burnout, AI-driven innovations, and the challenges of accessibility and affordability.From the potential of AI to streamline administrative tasks and improve patient care to the controversial role of government in healthcare, Dr. Runge doesn't shy away from hard truths. He discusses the obesity epidemic, the promise (and pitfalls) of drugs like Ozempic, and why a blended healthcare system—combining baseline government-provided care with optional private upgrades—could be the key to a healthier America.Whether you're frustrated with long wait times, high costs, or the complexities of modern medicine, this conversation offers fresh perspectives and provocative solutions. Tune in to hear why Dr. Runge believes disruption is exactly what healthcare needs—and how big tech and bold policy could reshape the future of American medicine.Dr. MARSCHALL RUNGE serves as Executive Vice President for Medical Affairs at the University of Michigan, dean of the Medical School, and CEO of Michigan Medicine. With advanced degrees from Vanderbilt and Johns Hopkins, and specialized training at Harvard's Massachusetts General Hospital, he has spent his career driving healthcare innovation and transforming medical education. His insights draw from decades of experience as both a practicing cardiologist and healthcare executive.

Bone marrow transplants used to be limited to just those people with sickle cell disease who could receive bone marrow from a matched donor. Rick Jones, an expert in blood disorders and cancers at Johns Hopkins, and colleagues have just … A new technique cures most people with sickle cell disease, Elizabeth Tracey reports Read More »

Headlines have announced that sickle cell disease can be cured with gene therapy. Now there's a better way developed at Johns Hopkins and other centers around the world, using what are called ‘half-matched donors,' to give new bone marrow to … A new technique is better than gene therapy for curing sickle cell disease, Elizabeth Tracey reports Read More »

Sickle cell disease was thought to be cured using gene therapy, but longer term follow up reveals that while the condition improves many are not cured. Now a new approach developed at Johns Hopkins and around the world uses ‘half-matched' … Sickle cell disease should be treated with a half-matched donor approach, Elizabeth Tracey reports Read More »

For years, Payson has maintained that Nichole is the most talented athlete in their household, but it wasn't until this winter that she finally decided to add some structure to her riding and shoot for some concrete goals. It all came about during an unusual lull in her schedule shortly after she and Payson finished his crossing project in New Zealand and got married in Tasmania, and just after she completed her capstone project for her Master's Degree in Public Health from Johns Hopkins. Payson and Nichole sat down to talk about how her tentative request for a training plan turned into an increasingly busy racing schedule. She started out by jumping into the four-day Sahara Gravel stage race in Morocco in February before winning the Central Missouri Circuit, a 340-mile ultra race, earlier this month. This weekend, she'll be lining up for the Unbound 100 in preparation for the Vapor Trail, a high-country bikepacking race later this year. Nichole talks about surprising herself in Morocco by discovering a thrill for racing, dealing with the heat, mental exhaustion, and fueling headaches during the overnight Central Missouri Circuit, and what it's been like having Payson as a coach. They also catch up on her studies at Johns Hopkins and how they relate to her work at the biopsy clinic in Uganda. For a more in-depth conversation about her work in pathology, listen to our episode from last year: Nichole Baker on her eighth year in Uganda for Path of LogicInstagram: @withpacepodYouTube: Payson McElveen

Matt Laslo's a veteran congressional correspondent, professor, writer and in-demand public speaker. At the Capitol, Matt operates The LCB (Laslo Congressional Bureau) — a regionally-focused, national wire service that brings the Capitol to life for millions. In 2023, Matt also founded Ask a Pol — a new, people-powered press corps. It now boasts an active community of thousands of subscribers, and is growing daily.  Since 2019, Matt's been a WIRED magazine contributor. Over the years, he's also been a regular contributor with VICE News, VICE News Tonight (HBO), Rolling Stone, Raw Story, The Daily Beast and Playboy, et. He's also an adjunct professor at a handful of universities, including Johns Hopkins and Boston University.Become a supporter of this podcast: https://www.spreaker.com/podcast/night-dreams-talk-radio-with-gary-anderson--2788432/support.

“HRT is probably the best thing that you can do to improve long term health and longevity,” explains Amy Killen, M.D. In this episode, we're covering everything you need to know about hormone replacement therapy, including the incredible benefits of HRT and when you should consider starting HRT.  You'll hear from: Maddy Dychtwald, author, longevity expert, and co-founder of Age Wave, on the study that changed the way HRT was viewed and why it's time to rethink that narrative  Marty Makay, M.D., the US Commissioner of Food and Drugs, a Johns Hopkins surgeon, public health expert, on why hormone replacement therapy may be one of the most powerful tools for women  Amy Killen, M.D., a longevity and regenerative medicine physician, on when to consider HRT and how it supports long-term health Jessica Shepherd, M.D., OB/GYN and menopause expert, on the different types of hormone therapy and how to find a provider who supports your goals We'll cover: - The flawed study that changed HRT perception (~1:05) - The incredible benefits of HRT (~4:15) - What about TRT for men? (~7:20) - Hormone health is longevity (~8:45) - When to consider HRT (~9:48) - The different types of HRT (~11:10) - You are the CEO of your health (~13:48) Listen to the full episodes here:  - Why women live longer, but not better | Longevity expert Maddy Dychtwald - The most common health myths, debunked | Marty Makary, M.D. - Stem cells, HRT, & nitric oxide for women | Amy Killen, M.D. - What women need to know about hormone replacement therapy (HRT) | Jessica Shepherd, M.D. Learn more about your ad choices. Visit megaphone.fm/adchoices

If you're a physician with at least 5 years of experience looking for a flexible, non-clinical, part-time medical-legal consulting role… ...Dr. Armin Feldman's Medical Legal Coaching program will guarantee to add $100K in additional income within 12 months without doing any expert witness work. Any doctor in any specialty can do this work. And if you don't reach that number, he'll work with you for free until you do, guaranteed. How can he make such a bold claim? It's simple, he gets results…  Dr. David exceeded his clinical income without sacrificing time in his full-time position. Dr. Anke retired from her practice while generating the same monthly consulting income.  And Dr. Elliott added meaningful consulting work without lowering his clinical income or job satisfaction. So, if you're a physician with 5+ years of experience and you want to find out exactly how to add $100K in additional consulting income in just 12 months, go to arminfeldman.com.                                                          =============== Learn the business and management skills you need by enrolling in the University of Tennessee Physician Executive MBA program at nonclinicalphysicians.com/physicianmba. Get the FREE GUIDE to 10 Nonclinical Careers at nonclinicalphysicians.com/freeguide. Get a list of 70 nontraditional jobs at nonclinicalphysicians.com/70jobs.                                                                                                 =============== Jonathan Jaffin, MD, is a trauma surgeon who earned his medical degree from Johns Hopkins and completed his general surgery residency through the National Capital Consortium, followed by a fellowship in surgical critical care at MedStar Georgetown. He dedicated over 30 years to the U.S. Army, taking on key leadership roles including Deputy Commander and Acting Commander of the Army Medical Research and Materiel Command, as well as CEO of the Walter Reed Health Care System. After retiring from military service, he transitioned into consulting as a Specialist Executive at Deloitte, one of the world's leading advisory firms—a unique path for a physician. Dr. Jaffin discusses how the leadership experience he gained in the military helped him succeed in consulting, where he provided strategic guidance to healthcare systems such as the VA and the Department of Defense. He talks candidly about the realities of life in consulting—frequent travel, the value of clinical experience in building client trust, and the importance of clear communication. He also emphasizes that while an MBA can be helpful, it's not essential if a physician has already built a strong foundation in leadership and professional relationships. He also shares practical advice for physicians considering consulting careers, such as taking on leadership roles, developing a strong network, and building credibility in a specific area of expertise. For those thinking about leaving clinical practice, he offers a reassuring perspective: it's still possible to make a meaningful impact by improving healthcare systems and policies that affect thousands of patients—not just one at a time. You'll find links mentioned in the episode at  nonclinicalphysicians.com/first-class-consulting/

In every generation, important people predict that the end is near and the apocalypse is coming. In the 1960s, the fear was that population growth would destroy the planet—that fertility would outrun the food supply, and hundreds of millions of people would starve to death. The most famous warning was 'The Population Bomb,' a bestselling book published in 1968 by Stanford ecologist Paul Ehrlich, which claimed "the battle to feed all of humanity is over" and “hundreds of millions of people would starve to death” in the 1970s. But then the 1970s came and went. And global famine deaths didn't rise. They declined by 90 percent. In the 1980s, deaths from world hunger fell again. And again in the 1990s. And again in the 2000s. The apocalypse that everybody said was coming never came. And the reason is, basically, we invented super wheat. In the 1950s and 1960s, a plant pathologist named Norman Borlaug, working in Mexico on fungus-resistant wheat on a grant from the Rockefeller Foundation, managed to create a breed of wheat that was super abundant, efficient, and disease-resistant. His work kickstarted what's known as the Green Revolution, a movement whose discoveries are responsible for keeping roughly half the planet alive. In 2007, when Borlaug was 93, The Wall Street Journal editorialized that he had “arguably saved more lives than anyone in history. Maybe one billion.” Today's guest is Charles C. Mann, a journalist and author. We talk about the long history of the Green Revolution. Who was Norman Borlaug? What did he actually do? How did he do it? What does his accomplishment teach us about science, invention, and progress? We're at a moment today when American science is being cut to the bone while foreign aid is being slashed. I sometimes hear the question: What is foreign aid really worth to us? I think it's important to remember that Norman Borlaug was a foundation-funded scientist who didn't do his most important work in air-conditioned labs at Harvard or Johns Hopkins. His breakthroughs came in lean-to shacks in Mexico, where he worked to improve harvests. Without Borlaug's accomplishments, the world would look very different: Famines might trigger migration that destabilizes countries and transforms global politics. The world we have today, where countries like China and India can easily feed their huge populations, is a gift to global stability, to humanity, to America. It grew from the seed of a foreign agricultural support program. If you have questions, observations, or ideas for future episodes, email us at PlainEnglish@Spotify.com. Host: Derek Thompson Guest: Charles C. Mann Producer: Devon Baroldi Learn more about your ad choices. Visit podcastchoices.com/adchoices

How did a utopian vision for society lead to one of the bloodiest regimes in history, Cambodia's Khmer Rouge? Why does it matter today? Was it mediocrity? Arrogance? Or is it just easier to seize power than it is to govern? Prof. Andrew Mertha of Johns Hopkins' School of International Studies, whose new book Bad Lieutenants – out today, lays it out for us.